HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Mechanisms of 2-butoxyethanol carcinogenicity: studies on Syrian Hamster Embryo (SHE) cell transformation.

Abstract
Previous studies showed that 2-butoxyethanol increased liver tumors in B6C3F1 mice following chronic exposure. While the mechanism of 2-butoxyethanol-induced liver carcinogenicity has not been defined, 2-butoxyethanol has been shown to induce hemolysis in rodents via 2-butoxyacetic acid, the major metabolite of 2-butoxyethanol. This toxic effect, coupled with the observation that continued treatment with 2-butoxyethanol results in hemosiderin deposition in the liver, has led to our hypothesis that liver carcinogenicity by 2-butoxyethnaol is mediated via oxidative stress (iron catalyzed) and Kupffer cell activation. The present study used Syrian Hamster Embryo (SHE) cell transformation, a surrogate in vitro model for carcinogenesis in vivo, to examine whether 2-butoxyethanol, 2-butoxyacetic acid, or iron (ferrous sulfate) produced cell transformation. SHE cells were treated with either 2-butoxyethanol (0.5-20 mM), 2-butoxyacetic acid (0.5-20 mM), or ferrous sulfate (0.5-75 microg/ml) for 7 days. 2-Butoxyethanol and 2-butoxyacetic acid did not induce cellular transformation. In contrast, treatment with ferrous sulfate (2.5 and 5.0 microg/ml) increased morphological transformation. Cotreatment of ferrous sulfate with the antioxidants alpha-tocopherol (vitamin E) or (-)-epigallocatechin-3-gallate (EGCG) prevented ferrous sulfate-induced transformation, suggesting the involvement of oxidative stress in SHE cell transformation. The level of oxidative DNA damage (OH8dG) increased following ferrous sulfate treatment in SHE cells; additionally, using single cell gel electrophoresis (comet assay), ferrous sulfate treatment produced an increase in DNA damage. Both DNA lesions were decreased by cotreatment of ferrous sulfate with antioxidants. These data support our proposal that iron, produced indirectly through hemolysis, and not 2-butoxyethanol or its metabolite 2-butoxyacetic acid, is responsible for the observed carcinogenicity of 2-butoxyethanol.
AuthorsJoungjoa Park, Lisa M Kamendulis, James E Klaunig
JournalToxicological sciences : an official journal of the Society of Toxicology (Toxicol Sci) Vol. 68 Issue 1 Pg. 43-50 (Jul 2002) ISSN: 1096-6080 [Print] United States
PMID12075109 (Publication Type: Journal Article)
Chemical References
  • Antioxidants
  • Drug Combinations
  • Ethylene Glycols
  • Ferrous Compounds
  • Glycolates
  • Mutagens
  • Solvents
  • Vitamin E
  • n-butoxyacetic acid
  • ferrous sulfate
  • Catechin
  • epigallocatechin gallate
  • n-butoxyethanol
Topics
  • Animals
  • Antioxidants (pharmacology)
  • Catechin (analogs & derivatives, pharmacology)
  • Cell Transformation, Neoplastic
  • Cells, Cultured
  • Comet Assay (methods)
  • Cricetinae
  • DNA Damage (drug effects)
  • Dose-Response Relationship, Drug
  • Drug Antagonism
  • Drug Combinations
  • Ethylene Glycols (toxicity)
  • Female
  • Ferrous Compounds (toxicity)
  • Glycolates (toxicity)
  • Mesocricetus
  • Mutagens (toxicity)
  • Pregnancy
  • Solvents (toxicity)
  • Vitamin E (pharmacology)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: